IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 46 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 42,313,000 | $38,610,613 | 3.33% |
| DeepCurrents Investment Group LLC | 79,898,000 | $72,811,602 | 2.83% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 101,490,000 | $92,463,904 | 2.20% |
| Sonora Investment Management Group, LLC | 18,890,000 | $17,161,843 | 1.56% |
| Penn Mutual Asset Management | 1,256,000 | $1,140,574 | 1.27% |
| BRAIDWELL LP | 36,533,000 | $33,358,282 | 1.12% |
| DLD Asset Management, LP | 13,750,000 | $12,561,038 | 1.05% |
| Worth Venture Partners, LLC | 1,278,000 | $1,164,178 | 0.69% |
| STEELHEAD PARTNERS LLC | 9,547,000 | $8,678,748 | 0.63% |
| Verition Fund Management LLC | 23,139,000 | $21,128,221 | 0.33% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 10,314,000 | $9,417,713 | 0.16% |
| AVIVA PLC | 30,000,000 | $27,255,000 | 0.13% |
| BOOTHBAY FUND MANAGEMENT, LLC | 5,527,000 | $5,043,388 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,740,000 | $4,307,373 | 0.12% |
| OAKTREE CAPITAL MANAGEMENT LP | 11,490,000 | $10,491,519 | 0.11% |
| CAMDEN ASSET MANAGEMENT L P /CA | 1,850,000 | $1,679,985 | 0.05% |
| Calamos Advisors LLC | 11,243,000 | $10,220,449 | 0.05% |
| D. E. Shaw & Co., Inc. | 38,485,000 | $35,088,591 | 0.04% |
| THRIVENT FINANCIAL FOR LUTHERANS | 14,845,000 | $13,481 | 0.04% |
| Oaktree Fund Advisors, LLC | 21,000 | $19,175 | 0.03% |
This page lists IONIS PHARMACEUTICALS INC's shareholders in Q4 2022. To view IONIS PHARMACEUTICALS INC's shareholder history, click here.